An organized cyberattack on the Singapore government’s health database caused a leak of 1.5 million patients’ records, including Prime Minister Lee Hsien Loong, for nearly an entire week.
Telemedicine helps Nashville-based Vanderbilt University Medical Center take its kidney transplant program to the people of Tennessee and give them the prospect to be screened for a transplant and bring constant care within their reach.
The FDA held up Mersana’s top antibody-drug conjugate (ADC), XMT-1522 over safety issues following a patient’s death in phase 1 trial, causing a descent in the company’s shares.
A report in Alimentary Pharmacology and Therapeutics revealed that Liver stiffness and liver fat (steatosis) in chronic hepatitis C virus (HCV) infected patients improved considerably post-treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR). A fall in ALT levels and a rise in platelet count was observed six months after SVR.
Cerebral palsy is a neurological disorder diagnosed during early childhood when a child is having problems with posture, gait and muscle tone. Cerebral palsy occurs due to damage of the cerebral portion of the brain that controls muscle tone and movements.
Type 1 diabetes is the most common metabolic disorder observed among children. It is a well-known fact that children who have diabetic parents are at higher risk of developing the disease.
The Newton Massachusetts-based company, Karyopharm Therapeutics, who developed a new class of drugs to treat multiple myeloma, is in the process of submitting a new drug application to the FDA for their selinexor drug.
A research team at the Imperial College London have developed a new sensor-based device to display fetal movements and growth in high-risk pregnancies. This is an alternative to the current self-reporting system where the mothers notice changes in fetus movements and seek medical help if needed.
After watching Scott Gottlieb, M.D. of the FDA comments regarding the rebate rule changes and a warning tweet on biosimilars, AbbVie investors are bailing out. But the industry watchers claim that they don’t need to be.
LabCorp, the mammoth medical investigations company, is still recuperating from a major ransomware attack and, almost a week later, won’t reveal how the hackers got entry nor the number of servers that were hit.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.